Sun Pharma to acquire oncology product from Novartis for $175 million
Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.
Dec 22, 2016, 11:21 AM IST